4
Changes in Ownership
Atea Pharmaceuticals, Inc. Filed Acc 0000950170-24-076379
Director sold 17,544 shares at $3.49 ($61,144)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Polsky Bruce Director | 2024-06-20 | Sale | −17,544 | $3.49 | $61,144 | 65,606 | D |
| Derivatives | |||||||
| Polsky Bruce Director | 2024-06-21 | Grant or award · Restricted Stock Units | +29,600 | 29,600 | D | ||
| Polsky Bruce Director | 2024-06-21 | Grant or award · Stock Option (Right to Buy) | +41,200 | 41,200 | D | ||
| Open-market sales · 17,544 sh · avg $3.49 · $61,144 | |||||||
Loading xslF345X05/ownership.xml…